NCT06455449 · Interventional trial
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Overall registry status Recruiting
Phase 3
Conditions Polymyositis, Dermatomyositis
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory